台灣醫院門診降血壓處方品質之多層次分析

A Multilevel Analysis of Quality of Outpatient Prescriptions to Treat Hypertension in Taiwan Hospitals

汪秀玲(Hsiu-Ling Wang)

《台灣公共衛生雜誌》 32卷2期 (2013/04) Pp. 192-204

https://doi.org/10.6288/TJPH2013-32-02-09

摘要

Objectives: To analyze inappropriate prescriptions at the market and hospital levels by examining antihypertensive medication ordering quality in out-patient departments (OPD) in Taiwan hospitals. Methods: Our sample included 398 accredited acute hospitals located in 23 regions. Information about hospital's ownership, rank, teaching status, OPD visits and hospital number published by the Department of Health (DOH) and information from the 2009-2011 Quality Database of Medications Indicators published by National Health Insurance were collected. The population density (PD) and physician density per 10000 population (PDPP) in the 23 regions were generated from DOH data. Two inappropriate prescription indicators were defined as duplicate medications of oral blood pressure-lowering agents or hypertension patients with a history of hyperkalemia using PSD or AA. We used MLLR models to assess multilevel effects on the probability of good or bad hospital quality for medications. The market concentration in the 23 regions was calculated by Herfindahl-Hirschman Index (H) using OPD visits to measure hospital competition. Results: Our study showed that higher H and PD led to greater probability of low duplicate medications. A higher PDPP led to lower probability of low duplicate medications. When compared to hospitals located in the Eastern region, the probability of low duplicate medications in Taipei, Southern, Kaohsiung-Pingtung areas is lower. The probability of low duplicate medications in teaching hospitals is lower than non-teaching hospitals and medical centers are higher than local hospitals. The probability of appropriately treating patients with hyperkalemia in Taipei, Northern, Southern, and Kaohsiung-Pingtung areas was higher than that of Eastern areas. Overall, the variation of medication quality can be explained 10.25%-17.63% by hospital-level variables and 73.40%-82.52% by market-level variables. Conclusions: Hospital and market characteristics impacted inappropriate prescriptions of anti-hypertensive drugs in the OPD setting over the past 3 years.

關鍵字

降血壓藥物 ； 處方品質 ； 醫院 ； 門診 ； 多層次邏吉斯迴歸

並列摘要

Objectives: To analyze inappropriate prescriptions at the market and hospital levels by examining antihypertensive medication ordering quality in out-patient departments (OPD) in Taiwan hospitals. Methods: Our sample included 398 accredited acute hospitals located in 23 regions. Information about hospital's ownership, rank, teaching status, OPD visits and hospital number published by the Department of Health (DOH) and information from the 2009-2011 Quality Database of Medications Indicators published by National Health Insurance were collected. The population density (PD) and physician density per 10000 population (PDPP) in the 23 regions were generated from DOH data. Two inappropriate prescription indicators were defined as duplicate medications of oral blood pressure-lowering agents or hypertension patients with a history of hyperkalemia using PSD or AA. We used MLLR models to assess multilevel effects on the probability of good or bad hospital quality for medications. The market concentration in the 23 regions was calculated by Herfindahl-Hirschman Index (H) using OPD visits to measure hospital competition. Results: Our study showed that higher H and PD led to greater probability of low duplicate medications. A higher PDPP led to lower probability of low duplicate medications. When compared to hospitals located in the Eastern region, the probability of low duplicate medications in Taipei, Southern, Kaohsiung-Pingtung areas is lower. The probability of low duplicate medications in teaching hospitals is lower than non-teaching hospitals and medical centers are higher than local hospitals. The probability of appropriately treating patients with hyperkalemia in Taipei, Northern, Southern, and Kaohsiung-Pingtung areas was higher than that of Eastern areas. Overall, the variation of medication quality can be explained 10.25%-17.63% by hospital-level variables and 73.40%-82.52% by market-level variables. Conclusions: Hospital and market characteristics impacted inappropriate prescriptions of anti-hypertensive drugs in the OPD setting over the past 3 years.

並列關鍵字

anti-hypertension agents ； prescriptions quality ； hospital ； outpatient ； multi-level logistic regression

參考文獻

柯景馨、莊明憲、陳永煌、羅慶徽、周稚傑(2007)。1998年台灣地區全民健保高血壓病患之人口學特徵與用藥情形。台灣家醫誌。17，12-9。

行政院衛生署中央健康保險局：藥品使用量分析。http://www.nhi.gov.tw/webdata/webdata.asp?menu=3&menu_id=56&webdata_id=2922&WD_ID=。引用2012/01/01。Bureau of National Health Insurance, Department of Health, Executive Yuan, R.O.C. (Taiwan). Drug dosage analysis.Available at: http://www.nhi.gov.tw/webdata/webdata.asp?menu=3&menu_id=56&webdata_id=2922&WD_ID=. Accessed January 1, 2012

Sipahi, I.,Debanne, S.M.,Rowland, D.Y.,Simon, D.I.,Fang, J.C.(2010).Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomized controlled trials.Lancet Oncol.11,627-36.

行政院衛生署國民健康局： 高血壓病患用藥 安全管理已具成效。http://health99.doh.gov.tw/Hot_News/h_NewsDetailN.aspx?TopIcNo=3256。引用2011/12/01。Bureau of Health Promotion, Department of Health, Executive Yuan, R.O.C. (Taiwan). The safe management of medication for hypertensive patients.Available at: http://health99.doh.gov.tw/Hot_News/h_NewsDetailN.aspx?TopIcNo=3256. Accessed December 1, 2011.

陳世欽、蔡文正、黃昱瞳、謝儀靜、黃光華(2012)。台灣高血壓用藥之問題處方及其影響因素的研究。台灣衛誌。31，31-42。